The diagnosis and management of interstitial lung diseases
A Wallis, K Spinks - Bmj, 2015 - bmj.com
The diagnosis and management of interstitial lung diseases | The BMJ Skip to main content
Intended for healthcare professionals Access provided by Google Indexer Subscribe My …
Intended for healthcare professionals Access provided by Google Indexer Subscribe My …
Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis-a review
K Kenn, R Gloeckl, J Behr - Respiration, 2013 - karger.com
Among the various types of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF) is
the most common disorder and has a poor prognosis and a limited response to …
the most common disorder and has a poor prognosis and a limited response to …
Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature
Background Patients with fibrotic interstitial lung disease have symptom control and quality
of life (QoL) needs. This review aims to evaluate the evidence for the use of interventions in …
of life (QoL) needs. This review aims to evaluate the evidence for the use of interventions in …
Pulmonary rehabilitation: overwhelming evidence but lost in translation?
K Johnston, K Grimmer-Somers - Physiotherapy Canada, 2010 - utpjournals.press
Purpose: This report highlights the current international gap between the availability of high-
quality evidence for pulmonary rehabilitation (PR) and its low level of implementation. Key …
quality evidence for pulmonary rehabilitation (PR) and its low level of implementation. Key …
Current best practice in rehabilitation in interstitial lung disease
A Nakazawa, NS Cox… - Therapeutic advances in …, 2017 - journals.sagepub.com
Interstitial lung disease (ILD) is a group of chronic respiratory diseases characterized by
dyspnoea on exertion and decline in health-related quality of life (HRQL). People with ILD …
dyspnoea on exertion and decline in health-related quality of life (HRQL). People with ILD …
Диагностика и лечение идиопатического легочного фиброза Федеральные клинические рекомендации
АГ Чучалин, СН Авдеев, ЗР Айсанов… - …, 2016 - journal.pulmonology.ru
Аннотация Представлены современные подходы к диагностике и терапии
идиопатического легочного фиброза (ИЛФ). Клинические рекомендации направлены …
идиопатического легочного фиброза (ИЛФ). Клинические рекомендации направлены …
Unclassifiable interstitial lung disease: a review
K Skolnik, CJ Ryerson - Respirology, 2016 - Wiley Online Library
Accurate classification of interstitial lung disease (ILD) requires a multidisciplinary approach
that incorporates input from an experienced respirologist, chest radiologist and lung …
that incorporates input from an experienced respirologist, chest radiologist and lung …
State of the art: how to set up a pulmonary rehabilitation program
S Jenkins, K Hill, NM Cecins - Respirology, 2010 - Wiley Online Library
Pulmonary rehabilitation plays an essential role in the management of symptomatic patients
with COPD. The benefits of rehabilitation include a decrease in dyspnoea and fatigue, and …
with COPD. The benefits of rehabilitation include a decrease in dyspnoea and fatigue, and …
Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study
SA Guler, S Am Hur, MK Stickland, P Brun, L Bovet… - Thorax, 2022 - thorax.bmj.com
Background The impact of pulmonary rehabilitation (PR) on survival in patients with fibrotic
interstitial lung disease (ILD) is unknown. Given the challenges conducting a large …
interstitial lung disease (ILD) is unknown. Given the challenges conducting a large …
King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference
CM Nolan, SS Birring, M Maddocks… - European …, 2019 - Eur Respiratory Soc
Health status is increasingly used in clinical practice to quantify symptom burden and as a
clinical trial end-point in patients with interstitial lung disease (ILD). The King's Brief …
clinical trial end-point in patients with interstitial lung disease (ILD). The King's Brief …